Clinical implications of the biopharmaceutical properties of fluvastatin

American Journal of Cardiology - Tập 73 - Trang D12-D17 - 1994
Jean-Paul Deslypere1
1From the Department of Internal Medicine, University Hospital, Gent, Belgium

Tài liệu tham khảo

Tse, 1992, Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers, J Clin Pharmacol, 32, 630, 10.1002/j.1552-4604.1992.tb05773.x Choc, 1989, S 1994 McTavish, 1991, Pravastatin: a review of its pharmacological properties and therapeutic potential in hypercholesterolaemia, Drugs, 42, 65, 10.2165/00003495-199142010-00005 Walker, 1988, MHG CoA reductase inhibitors: current clinical experience, Drugs, 36, 83, 10.2165/00003495-198800363-00017 Davidson, 1993, Fluvastatin long-term extension trial (FLUENT): summary of efficacy and safety. (Abstr.) Smith, 1993, Pharmacokinetks of fluvastatin and specific drug interactions, Am J Hypertens, 6, 375S, 10.1093/ajh/6.11.375S 1992, Nicolar product information, 1846